The scientist’s investigation covers issues in Pathology, Head and neck squamous-cell carcinoma, Cancer research, Cancer and Carcinoma. His biological study spans a wide range of topics, including Tumor progression, Gene and Microsatellite. The subject of his Head and neck squamous-cell carcinoma research is within the realm of Head and neck cancer.
His work carried out in the field of Cancer research brings together such families of science as Methylation, DNA methylation, Mutation, Tumor suppressor gene and Epigenetics. Cancer is a subfield of Internal medicine that Joseph A. Califano investigates. His Carcinoma research incorporates themes from Malignant transformation, Skin cancer, Saliva, Immunology and Biomarker.
Head and neck squamous-cell carcinoma, Cancer research, Cancer, Pathology and DNA methylation are his primary areas of study. His Head and neck squamous-cell carcinoma study combines topics from a wide range of disciplines, such as Gene expression, Oncology and Bioinformatics. He has researched Cancer research in several fields, including Cell, Cell growth and Carcinogenesis, Tumor suppressor gene, Gene.
His Cancer study incorporates themes from Mutation, Dysplasia and Immunology. His studies deal with areas such as Mitochondrial DNA, Saliva and Loss of heterozygosity as well as Pathology. His study looks at the relationship between DNA methylation and fields such as Methylation, as well as how they intersect with chemical problems.
Joseph A. Califano mainly investigates Head and neck squamous-cell carcinoma, Cancer research, Internal medicine, Oncology and Cancer. Head and neck squamous-cell carcinoma is a subfield of Head and neck cancer that Joseph A. Califano studies. Joseph A. Califano has included themes like Cell, Cell growth, DNA methylation, Regulation of gene expression and Notch signaling pathway in his Cancer research study.
His DNA methylation research is multidisciplinary, relying on both EGFR inhibitors and Omics. His studies in Oncology integrate themes in fields like Tumor suppressor gene, Risk stratification, Radiation therapy and Immunotherapy. His research in Cancer intersects with topics in Human papillomavirus, Malignancy, Incidence and Gene isoform.
Joseph A. Califano spends much of his time researching Head and neck squamous-cell carcinoma, Internal medicine, Oncology, Cancer research and Cancer. His Head and neck squamous-cell carcinoma research integrates issues from Carcinogenesis, Tumor suppressor gene, Immune system, Primary tumor and Epigenetics. In his work, Physical therapy, Oral pharyngeal, Dysphagia, Quality of life and Feeding tube is strongly intertwined with Otorhinolaryngology, which is a subfield of Internal medicine.
His Oncology study also includes fields such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1
Nishant Agrawal;Mitchell J. Frederick;Curtis R. Pickering;Chetan Bettegowda.
Science (2011)
Genetic progression model for head and neck cancer: Implications for field cancerization
Joseph Califano;Peter Van Der Riet;William Westra;Homaira Nawroz.
Cancer Research (1996)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence;Carrie Sougnez;Lee Lichtenstein;Kristian Cibulskis.
Nature (2015)
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
Mingzhao Xing;William H. Westra;Ralph P. Tufano;Yoram Cohen.
The Journal of Clinical Endocrinology and Metabolism (2005)
Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database
André Lopes Carvalho;Inês Nobuko Nishimoto;Joseph A. Califano;Luiz Paulo Kowalski.
International Journal of Cancer (2005)
High Frequency of p16 (CDKN2/MTS-1/INK4A) Inactivation in Head and Neck Squamous Cell Carcinoma
Andre L. Reed;Joseph Califano;Paul Cairns;William H. Westra.
Cancer Research (1996)
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
P. Cairns;T. J. Polascik;Y. Eby;K. Tokino.
Nature Genetics (1995)
TP53 mutations and survival in squamous-cell carcinoma of the head and neck.
M. Luana Poeta;M. Luana Poeta;Judith Manola;Meredith A. Goldwasser;Arlene Forastiere.
The New England Journal of Medicine (2007)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini;Kristen Meckel;Michael Kelso;Kimberly Noonan.
Journal of Experimental Medicine (2006)
Promoter Hypermethylation Patterns of p16, O6-Methylguanine-DNA-methyltransferase, and Death-associated Protein Kinase in Tumors and Saliva of Head and Neck Cancer Patients
Siane Lopes Bittencourt Rosas;Siane Lopes Bittencourt Rosas;Wayne Koch;Maria da Gloria da Costa Carvalho;Li Wu.
Cancer Research (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Johns Hopkins University School of Medicine
Icahn School of Medicine at Mount Sinai
Johns Hopkins University
University of California, San Diego
University of California, San Diego
Pennsylvania State University
Johns Hopkins University
Yenepoya University
Johns Hopkins University
The University of Texas MD Anderson Cancer Center
TU Wien
Texas State University
Osaka University
University of Adelaide
Academia Sinica
University of California, San Francisco
Monash University
Ariel University
Scottish Universities Environmental Research Centre
Los Alamos National Laboratory
University of Maryland, College Park
Université Paris Cité
University of Amsterdam
Karolinska Institute
University of Toronto
Duke University